TBK1 binds amlexanox

Stable Identifier
R-HSA-9679819
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

The Serine/threonine-protein kinase TBK1 binds amlexanox, a small-molecule drug that reduces imflammatory processes associated with obesity (Reilly et al. 2013). TBK1 is a component of a signaling cascade that targets IRF3, which in turn appears to be a key mediator of the resistance observed in bats to symptoms of coronavirus infection (Banerjee et al. 2020).

Literature References
PubMed ID Title Journal Year
23396211 An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice

Reilly, SM, Chiang, SH, Decker, SJ, Chang, L, Uhm, M, Larsen, MJ, Rubin, JR, Mowers, J, White, NM, Hochberg, I, Downes, M, Yu, RT, Liddle, C, Evans, RM, Oh, D, Li, P, Olefsky, JM, Saltiel, AR

Nat. Med. 2013
Participants
Participant Of
Authored
Reviewed
Created
Cite Us!